Carboplatin
Also known as: cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
Brand names: PARAPLATIN
Therapeutic Indications
Carboplatin is indicated for:
Small cell carcinoma of the lung
Irrespective of gender only Adults (18 years old or older)
Carboplatin is indicated for the treatment of small cell carcinoma of the lung.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 200-400 mg/m² once every 21 days
Advanced ovarian carcinoma of epithelial origin
Women only, only Adults (18 years old or older)
Carboplatin is indicated for the treatment of:
- Advanced ovarian carcinoma of epithelial origin in:
- first line therapy
- second line therapy, after other treatments have failed.
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 200-400 mg/m² once every 21 days
Contraindications
Active ingredient Carboplatin is contraindicated in the following cases:
Severe renal impairment (creatinine clearance of ≤30 ml per minute)
No gender/age discrimination
Yellow fever vaccines
No gender/age discrimination
Severe myelosuppression
No gender/age discrimination
Bleeding tumors
No gender/age discrimination